Critical management of status epilepticus | 47928

Journal of Neurology & Neurophysiology

ISSN - 2155-9562

Critical management of status epilepticus

International Conference on Central Nervous System - Drug Effects & Novel Drug Development

September 5-7, 2012 DoubleTree by Hilton Philadelphia Center City, USA

Farahnaz Fallahian and Seyed Mohammad Reza Hashemian

Scientific Tracks Abstracts: J Neurol Neurophysiol

Abstract :

Status epilepticus (SE) is a medical emergency and requires prompt diagnosis and treatment. Treatment includes general support measures, drugs to suppress epileptic activity and relieving the underlying condition. Refractory SE requires admission to an intensive care unit (ICU) to allow adequate monitoring and support of respiratory, metabolic and hemodynamic functions and cerebral electrical activity. For SE treatment, benzodiazepines are the first line antiepileptic agents, and if benzodiazepines fail to control seizures, phenytoin is usually indicated, phenobarbital or valproate may also be considered. For refractory SE, propofol and thiopental represent first line agents after careful assessment of potential risks. In refractory SE, general anesthesia may be required. There is currently no unique consensus for definite treatment option of RSE in children and adults. In this review, the management protocol of seizure, assessment, monitoring, analysis the causes, different alternative therapy, and manage of complications would be discussed.

Biography :

F.Fallahian has completed internal medicine specialty and passed clinical ICU fellowship, graduated from Tehran University of Medical Sciences with a history of working in research centers and published about 30 articles in this field in Iranian and international journals.